LGC announces changes to its Executive Leadership Team

News - These changes follow recent strong trading performance and further strategy endorsement by Cinven and Astorg, LGC’s new shareholders.

17 June 2020
LGC acquires The Native Antigen Company, strengthening its offer to the IVD sector

News - Acquisition strengthens LGC’s existing product offering to IVD sector, which includes quality assurance tools, immunoassay reagents and disease state plasma 

09 July 2020
LGC expands SARS-CoV-2 molecular solutions to full genome coverage

News - Expansion allows for compatibility with any SARS-CoV-2 assay target, while maintaining safety features

15 July 2020
LGC SeraCare SARS-CoV-2 Molecular Controls Kit now CE-Marked

News - Bearing the CE mark and IVD symbol signifies that the AccuPlex SARS-CoV-2 Molecular Controls Kit meets extensive design control requirements

28 July 2020